117 results
8-K
EX-99.1
ZLAB
Zai Lab Limited
8 May 24
Zai Lab Announces First Quarter 2024
4:09pm
innovative business models and resource integration will help us further enhance our commercial operations and drive sales and profit growth across … Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We
S-3ASR
ZLAB
Zai Lab Limited
19 Apr 24
Automatic shelf registration
5:11pm
of this prospectus.
OUR COMPANY
We are a patient-focused, innovative, commercial-stage, global biopharmaceutical company with a substantial presence
8-K
EX-99.1
c511ondlbxidgyp120z5
27 Feb 24
Zai Lab Announces Full-Year 2023
4:12pm
8-K
EX-99.1
2f7ud
7 Nov 23
Zai Lab Announces Third Quarter 2023
4:10pm
8-K
EX-99.1
kpjsh2
7 Aug 23
Zai Lab Announces Second Quarter 2023
4:07pm
8-K
EX-99.1
358xxbpokr ue
6 Jul 23
Zai Lab Announces Promotion of Yajing Chen to Chief Financial Officer
4:14pm
8-K
EX-99.1
frjbcz 2l1r
30 Jun 23
Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China
4:18pm
8-K
EX-99.1
8dms 10kj43mch3
6 Jun 23
Other Events
8:08am
8-K
EX-99.1
hzs2wsgtrgkf5c
9 May 23
Zai Lab Announces First Quarter 2023
4:03pm
8-K
EX-99.1
7pt5tstx9z6upw4hw
9 Nov 22
Zai Lab Announces Third Quarter 2022
4:13pm